The burgeoning landscape of innovative treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a https://hamzahmaph151263.blogacep.com/44295799/retatrutide-vs-tirzepatide-a-comparative-analysis